A. Arizpe

Regional variation in antibiotic prescribing among medicare part D enrollees, 2013

S. Aitken, K. Reveles, A. Arizpe, 2016, BMC Infectious Diseases.

Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria

S. Aitken, K. Reveles, Shrina D. Patel, 2016, Current Infectious Disease Reports.

Dose-dependent durability of hepatitis B surface antigen reductions following administration of a single dose of VIR-3434, a novel neutralizing vaccinal monoclonal antibody

M. Yuen, H. Wedemeyer, L. Seu, 2022, Journal of Hepatology.

Longer treatment duration of monthly VIR-2218 results in deeper and more sustained reductions in hepatitis B surface antigen in participants with chronic hepatitis B infection

M. Yuen, A. Cathcart, E. Gane, 2022, Journal of Hepatology.

Global importance of new treatment strategies to efforts to control hepatitis B virus

V. Thanawala, Ling Shen, A. Arizpe, 2023, Expert review of anti-infective therapy.